(Q34959992)

5 August 2017

1 reference

title

Abnormalities in glucose regulation associated with mental illness and treatment (English)

1 reference

5 August 2017

John W Newcomer

2

1 reference

ORCID Public Data File 2021

author name string

Dan W Haupt

series ordinal

1

1 reference

5 August 2017

publication date

1 October 2002

1 reference

Journal of Psychosomatic Research

5 August 2017

published in

1 reference

5 August 2017

volume

53

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

925-933

1 reference

Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Overview: toward a dysregulation hypothesis of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Metabolic abnormalities in visceral obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

A review of functional neuroimaging in mood disorders: positron emission tomography and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Vasoactive intestinal peptide and noradrenaline exert long-term control on glycogen levels in astrocytes: blockade by protein synthesis inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Memory improvement following induced hyperinsulinemia in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Use of imipramine in diabetics. Effects on glycosuria and blood sugar levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Doxepin therapy for postprandial symptomatic hypoglycaemic patients: neurochemical, hormonal and metabolic disturbances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Tranylcypromine: A Potent Insulin Secretagogue and Hypoglycemic Agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Inhibition of insulin release by substrates and inhibitors of monoamine oxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

The influence of some antidepressives of the hydrazine type on the glucose metabolism in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Possible Role of Hydrazine Group in Hypoglycemia Associated with the Use of Certain Monoamine-oxidase Inhibitors (MAOI's)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Fluoxetine in the treatment of obese type 2 diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Hyperglycemia associated with paroxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Manic-Depressive Illness, Diabetes Mellitus, and Lithium Carbonate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Carbohydrate metabolism in mania before and after lithium carbonate treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Diabetes mellitus in patients on lithium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Effects of lithium, nortriptyline and dexamethasone on insulin sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Assisting effects of lithium on hypoglycemic treatment in patients with diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Phenothiazines and Diabetes in Hospitalized Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

The effect of chlorpromazine on serum cholesterol in chronic schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Psychotropic drugs, diabetes and chronic mental patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Clozapine-associated diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

New-onset diabetes mellitus associated with the initiation of quetiapine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Resolution of hyperglycemia on risperidone discontinuation: a case report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Risperidone-associated new-onset diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Schizophrenia and diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Diabetic ketoacidosis associated with risperidone treatment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Risperidone-associated diabetic ketoacidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Undiagnosed NIDDM: clinical and public health issues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Atypical antipsychotic drugs and hyperglycemia in adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Diabetic ketoacidosis associated with clozapine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Diabetic ketoacidosis associated with clozapine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Euglycemic clamp study in clozapine-induced diabetic ketoacidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

The Positive Correlation between Insulin Resistance and Duration of Hospitalization in Untreated Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Body weight gain induced by antipsychotic drugs: mechanisms and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

The link between diabetes and schizophrenia: an immunological explanation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Insulin therapy and risk of retinopathy in type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Dopamine receptor antagonists modulate glucose uptake in rat pheochromocytoma (PC12) cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Effect of chlorpromazine on blood glucose and plasma insulin in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

A kinetic study of chlorpromazine on the hyperglycemic response in rats. II. Effect of chlorpromazine on plasma glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

The effect of norepinephrine on insulin secretion and glucose effectiveness in non-insulin-dependent diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

Dose-dependent cortisol-induced increases in plasma leptin concentration in healthy humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900471-3

10.1016/S0022-3999(02)00471-3

7 January 2021

Identifiers

DOI

1 reference

release_tgaqtczrobaq3ja33nc5jzmvpu

5 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tgaqtczrobaq3ja33nc5jzmvpu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference